Application of Fragment Screening by X-ray Crystallography to the Discovery of Aminopyridines as Inhibitors of β-Secretase

Journal of Medicinal Chemistry
2007.0

Abstract

Fragment-based lead discovery has been successfully applied to the aspartyl protease enzyme beta-secretase (BACE-1). Fragment hits that contained an aminopyridine motif binding to the two catalytic aspartic acid residues in the active site of the enzyme were the chemical starting points. Structure-based design approaches have led to identification of low micromolar lead compounds that retain these interactions and additionally occupy adjacent hydrophobic pockets of the active site. These leads form two subseries, for which compounds 4 (IC50 = 25 microM) and 6c (IC50 = 24 microM) are representative. In the latter series, further optimization has led to 8a (IC50 = 690 nM).

Knowledge Graph

Similar Paper

Application of Fragment Screening by X-ray Crystallography to the Discovery of Aminopyridines as Inhibitors of β-Secretase
Journal of Medicinal Chemistry 2007.0
Application of Fragment Screening by X-ray Crystallography to β-Secretase
Journal of Medicinal Chemistry 2007.0
From Fragment Screening to In Vivo Efficacy: Optimization of a Series of 2-Aminoquinolines as Potent Inhibitors of Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1)
Journal of Medicinal Chemistry 2011.0
Tyramine fragment binding to BACE-1
Bioorganic & Medicinal Chemistry Letters 2008.0
Cyanobacterial Peptides as a Prototype for the Design of Potent β-Secretase Inhibitors and the Development of Selective Chemical Probes for Other Aspartic Proteases
Journal of Medicinal Chemistry 2012.0
Discovery of 7-Tetrahydropyran-2-yl Chromans: β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors That Reduce Amyloid β-Protein (Aβ) in the Central Nervous System
Journal of Medicinal Chemistry 2014.0
Aminoindazole PDK1 Inhibitors: A Case Study in Fragment-Based Drug Discovery
ACS Medicinal Chemistry Letters 2010.0
Naphthyl and Coumarinyl Biarylpiperazine Derivatives as Highly Potent Human β-Secretase Inhibitors. Design, Synthesis, and Enzymatic BACE-1 and Cell Assays
Journal of Medicinal Chemistry 2006.0
Identification of Novel p38α MAP Kinase Inhibitors Using Fragment-Based Lead Generation
Journal of Medicinal Chemistry 2005.0
Triazole-linked reduced amide isosteres: An approach for the fragment-based drug discovery of anti-Alzheimer’s BACE1 inhibitors
Bioorganic & Medicinal Chemistry Letters 2011.0